发明公开
EP0874849A1 2,7-SUBSTITUTED OCTAHYDRO-PYRROLO 1,2-A]PYRAZINE DERIVATIVES 失效
2,7-取代的八氢 - 吡咯(1,2-a)的吡嗪

  • 专利标题: 2,7-SUBSTITUTED OCTAHYDRO-PYRROLO 1,2-A]PYRAZINE DERIVATIVES
  • 专利标题(中): 2,7-取代的八氢 - 吡咯(1,2-a)的吡嗪
  • 申请号: EP96935226.0
    申请日: 1996-11-06
  • 公开(公告)号: EP0874849A1
    公开(公告)日: 1998-11-04
  • 发明人: SANNER, Mark, A.
  • 申请人: PFIZER INC.
  • 申请人地址: 235 East 42nd Street New York, N.Y. 10017 US
  • 专利权人: PFIZER INC.
  • 当前专利权人: PFIZER INC.
  • 当前专利权人地址: 235 East 42nd Street New York, N.Y. 10017 US
  • 代理机构: Ruddock, Keith Stephen, et al
  • 优先权: US19950008988P 19951221
  • 国际公布: WO1997023482 19970703
  • 主分类号: A61K31
  • IPC分类号: A61K31 A61P1 A61P9 A61P25 A61P27 A61P39 C07D487 C07D209 C07D241
2,7-SUBSTITUTED OCTAHYDRO-PYRROLO 1,2-A]PYRAZINE DERIVATIVES
摘要:
This invention relates to compounds of formula (I), wherein R1 is phenyl, naphthyl, benzoxazolonyl, indolyl, indolonyl, benzimidazolyl, quinolyl, furyl, benzofuryl, thienyl, benzothienyl, oxazolyl, benzoxazolyl; R2 is H or (C1-C6)alkyl; R3 is phenyl, pyridinyl, pyrimidinyl, pyrazinyl, or pyridazinyl; X is O, S, SO, SO2, NR4, C=O, CH(OH), CHR4, (a), (b), (c), or (d); m is 0, 1 or 2; n is 0, 1 or 2. The compounds of this invention are ligands for dopamine receptor subtypes, especially the dopamine D4 receptor, and are therefore useful in the treatment of disorders of the dopamine system.
信息查询
0/0